The goal of the "Berlin School of Integrated Oncology (BSIO)" is to train the next generation of researchers and physicians specialized in cancer. Since 2012 the BSIO has been led by its founding spokesperson, Prof. Clemens Schmitt and is funded by the Excellence Initiative of the German federal and state governments. In the Graduate School, young scientists from Charité – Universitätsmedizin, Humboldt-Universität zu Berlin, Freie Universität Berlin, the Max Delbrück Center for Molecular Medicine, and other partner organizations are trained in cancer research in a three-year program. Il-Kang Na, BIH Johanna Quandt Professor of Translational Medicine and cancer researcher in the field of immunoncology, heads the program since January 2019. "The graduate school is based at the interface of bioscientific research and clinical application and therefore fits in perfectly with BIH's mission to transfer results from basic research to application," explains Na.
Together, Schmitt and Na were able to win the Einstein Award for Doctoral Programmes 2019.